Three of the most powerful repair and renewal peptides combined into one ready-to-use injectable. GLOW repairs damaged tissue, reduces inflammation, and rebuilds the skin, collagen, and connective tissue that aging and injury wear down over time.
This is the protocol for clients who want comprehensive recovery and visible renewal — faster healing and a more youthful appearance, addressed together.
GLOW combines three peptides that each target a different repair and renewal pathway. Used together, they do more than any single peptide can — and they don't overlap. Each one handles a different job, and all three are more effective because the others are present.
Repair and renewal aren't separate processes — they're connected. Inflammation slows tissue healing. Poor circulation limits how quickly repair cells reach an injury. Low collagen means slower recovery and accelerated aging in skin and joints. GLOW addresses all three links in that chain at the same time.
BPC-157 targets the injury site directly. TB-500 works body-wide — reducing inflammation and mobilizing healing cells to wherever they're needed. GHK-Cu rebuilds the collagen and elastin matrix that holds everything together, while also activating gene expression pathways associated with younger, more resilient cells. Each ingredient amplifies the others.
What makes GLOW different from BPC-157 & TB-500 alone? GHK-Cu (Copper Peptide) is what separates GLOW from the standard BPC-157/TB-500 Wolverine Stack. It adds a third layer of renewal — stimulating collagen and elastin synthesis, improving skin texture and firmness, supporting hair thickness, and activating genes linked to cellular longevity. If aesthetic renewal and anti-aging are part of your goals alongside physical repair, GLOW is the appropriate formula.
Most people feel reduced inflammation and improved joint comfort within the first 1–2 weeks. Structural tissue repair builds through weeks 2–4. Visible skin and collagen changes from GHK-Cu typically appear through weeks 3–6 of the active cycle.
BPC-157 and TB-500 together target structural tissue healing from two angles — BPC-157 drives repair directly at the injury site while TB-500 works body-wide to reduce the inflammation that slows everything down and send repair cells where they're needed. This combination is particularly effective for chronic injuries that haven't fully healed on their own.
GHK-Cu is one of the most potent naturally-occurring signals for collagen and elastin production in the body. Within a 4–6 week active cycle, users typically notice improved skin firmness, reduced fine lines, and more even texture. These changes reflect actual structural protein being rebuilt beneath the skin's surface — not surface-level treatment.
Both BPC-157 and TB-500 have strong anti-inflammatory effects — BPC-157 targets localized inflammation at injury sites, while TB-500 addresses systemic inflammation throughout the body. Most users report meaningful reduction in joint discomfort, stiffness, and swelling within the first 1–2 weeks of the protocol.
GHK-Cu has well-documented effects on hair follicle function — it extends the active growth phase of hair follicles, improves follicle density, and increases hair thickness. Users on consistent GLOW cycles often report noticeably fuller and healthier hair as a secondary benefit that compounds over multiple cycles.
The BPC-157 and TB-500 combination reduces post-exercise inflammation and accelerates muscle fiber repair, allowing harder training with shorter recovery windows. GHK-Cu adds an additional layer of connective tissue support — helping tendons and ligaments rebuild faster so they keep pace with muscle development and resist cumulative overuse injury.
GHK-Cu has been shown to alter gene expression in ways that favor repair and resilience — activating antioxidant and renewal pathways while quieting the inflammatory signals that drive cellular aging. Over a full 4–6 week active cycle, users often notice a broad sense of physical renewal: less discomfort, better recovery, improved skin, and more resilient overall health that builds across multiple cycles.
GLOW and KLOW share the same three ingredients. KLOW adds a fourth — KPV — specifically for clients with gut or immune conditions.
| If your main concern is… | GLOW | KLOW |
|---|---|---|
| Tissue repair, tendon or muscle recovery | ✓ Strong | ✓ Strong |
| Skin, collagen, and aesthetic renewal | ✓ Strong | ✓ Strong |
| General recovery and physical renewal | ✓ Ideal | ✓ Ideal |
| Gut inflammation, leaky gut, or IBS | Partial (BPC-157 only) | Full support (BPC-157 + KPV) |
| Mast cell activation or immune dysregulation | Minimal | Targeted (KPV) |
| Post-viral recovery or systemic inflammation | Partial | Full support (KPV + TB-500) |
Highlighted rows = where KLOW adds meaningful benefit over GLOW. If gut health, immune regulation, or chronic inflammation are part of your picture, KLOW is the more appropriate choice. For repair and aesthetic renewal without those concerns, GLOW is the ideal formula.
GLOW uses a two-phase protocol — a lighter starting dose in Week 1, then the full dose from Week 2 onward. Both phases use the same 5-days-on / 2-days-off schedule. Your vial comes as a ready-to-use liquid. No mixing or preparation required.
| Phase | Dose | Schedule | What to expect |
|---|---|---|---|
| Week 1 | 0.1 mL (dial 10) | 5 days on / 2 days off | Adjustment week — reduced inflammation, improved comfort |
| Week 2+ | 0.15 mL (dial 15) | 5 days on / 2 days off | Full repair and collagen renewal builds through weeks 2–6 |
| Method | Subcutaneous — just under the skin, not into muscle | ||
| Sites | Abdomen or upper thigh — rotate sites each week | ||
Using a pen injector? Week 1: dial to 10 (0.1 mL). Week 2+: dial to 15 (0.15 mL). Press the button until the dial returns to "0," then hold the needle in place for 5 seconds before removing. Always use a fresh needle and dispose in a sharps container immediately after use.
Step-by-step injection guide
Pre-set to your standard doses: Week 1 — 10 units (0.1 mL) and Week 2+ — 15 units (0.15 mL). Enter your vial details and the calculator shows exactly how long your vial lasts across both phases. Defaults to a standard 60 mg total combo vial in 3 mL.
If your vial is a different size, update the mg and mL fields and all outputs recalculate automatically.
= 20.0 mg/mL total blend · each unit = 0.20 mg
Always confirm the concentration printed on your vial label. The GHK-Cu component (50 mg) is at a higher concentration than BPC-157 and TB-500 (5 mg each). The calculator uses total blend mg/mL — your provider may give ingredient-specific guidance that takes priority.
Based on a standard 60 mg combo vial (5 mg BPC-157 / 5 mg TB-500 / 50 mg GHK-Cu) in 3 mL = 20 mg/mL total. On a U-100 syringe: 1 unit = 0.01 mL = 0.20 mg total blend.
| Phase | Units | Volume | BPC-157 | TB-500 | GHK-Cu | Shots / vial |
|---|---|---|---|---|---|---|
| Week 1 | 10 units | 0.10 mL | ~167 mcg | ~167 mcg | ~1.67 mg | 30 shots |
| Week 2+ | 15 units | 0.15 mL | ~250 mcg | ~250 mcg | ~2.50 mg | 20 shots |
At 5 injections/week: Week 1 uses 5 shots (half a week of the 30-shot count). Transitioning to 15 units from Week 2 gives you approximately 20 shots — covering 4 weeks at 5 injections/week. One vial comfortably covers a full 4–5 week cycle across both phases.
Side effects are mild and typically appear only in the first week. The two-phase dosing protocol is designed specifically to minimize them. Contact your provider if anything feels unusual or doesn't clear up on its own.
USA-formulated, lab-verified liquid formula. Three peptides combined and ready to use — no mixing required. Includes full dosing guidance from our clinical team.
Schedule Consultation